Search

Displaying results 7411 - 7420 of 10000 in total
  1. Drug

    Zerencotrep

    go.drugbank.com/drugs/DB21710
    Experimental

    The usage of the INN stem '-cotrep' in the name indicates that Zerencotrep is a transient receptor potential canonical channel 5 (TRPC5) antagonist.

  2. Drug

    Stannsoporfin

    go.drugbank.com/drugs/DB04912
    Investigational

    Stannsoporfin is a competitive heme oxygenase (HO) inhibitor being developed by InfaCare, a subsidiary of WellSpring Pharmaceuticals, for the prevention of hyperbilirubinemia in infants at risk of developing

  3. Drug

    Mesoheme

    go.drugbank.com/drugs/DB02577
    Experimental

    The color-furnishing portion of hemoglobin. It is found free in tissues and as the prosthetic group in many hemeproteins.

  4. Drug

    Malonyl-CoA

    go.drugbank.com/drugs/DB04524
    Experimental

    A coenzyme A derivative which plays a key role in the fatty acid synthesis in the cytoplasmic and microsomal systems.

  5. Drug

    Inakalant

    go.drugbank.com/drugs/DB20424
    Investigational

    The usage of the INN stem '-kalant' in the name indicates that Inakalant is a potassium channel blocker. … Inakalant is under investigation in clinical trial NCT00255281 (Efficacy and Safety of AZD7009 in the Treatment of Atrial Fibrillation). Inakalant has a monoisotopic molecular weight of 446.25 Da.

  6. Drug

    ZEN-012

    go.drugbank.com/drugs/DB06042
    Experimental

    It is developed for the treatment of solid tumors. … ZEN-012 is a novel small molecule and the first anti-cancer drug in development involving two mechanisms of action: tubulin and topoisomerase II inhibition.

  7. Drug

    ATX-101

    go.drugbank.com/drugs/DB05780
    Investigational

    of the body. … As a naturally occurring component of the human body, deoxycholate is considered a ‘biocompatible’ detergent that solubilizes fat in the small intestine.

  8. Drug

    BZL101

    go.drugbank.com/drugs/DB05051
    Investigational

    BZL101 is an oral drug designed for the treatment of advanced breast cancer with a novel mechanism of action. BZL101 targets diseased cells while leaving normal cells healthy and intact.

  9. Drug

    Inodiftagene vixteplasmid

    go.drugbank.com/drugs/DB16017
    Investigational

    Inodiftagene vixteplasmid is a plasmid DNA vector encoding the diphtheria toxin A (dT-a) gene under transcriptional regulation of the promoter region of the human H19 gene (an imprinted maternally expressed

    Synonyms: Dna Plasmid Expressing Diphtheria Toxin Triggered By The Presence Of Oncofetal Gene H19
  10. Drug

    Detirelix

    go.drugbank.com/drugs/DB19488
    Experimental

    The usage of the INN stem '-relix' in the name indicates that Detirelix is a gonadotropin-releasing-hormone (GnRH) inhibitor. Detirelix has a monoisotopic molecular weight of 1536.78 Da.